Work

Retrospective analysis of toxicities and clinical outcomes with BCR-ABL1 tyrosine kinase inhibitors in B-cell acute lymphoblastic leukemia.

Year: 2022

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2022.40.16_suppl.e19039

Authors: Chad Michael Venn, Kyle Zacholski, Valerie Tran, Yanal Mufeed Alnimer, Thuy Ho, Keri Renee Maher, Ian Michael Bouligny

Institutions: Virginia Commonwealth University, Virginia Commonwealth University Medical Center, VCU Massey Comprehensive Cancer Center

Language: English

Topic: Acute Lymphoblastic Leukemia research

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4286297058

Cites:

Cited by:

Related to: 10